Recent Editions of IMPAQ Health News
This edition of IMPAQ Health News highlights stories on the intersection of COVID-19 and movements for social justice, racial and ethnic disparities of the pandemic, and the growing mental health crisis.
Learn about the psychological toll of COVID-19, testing and contact tracing efforts, and possible effects on Medicaid providers and beneficiaries in this edition of IMPAQ Health News.
In this week’s edition, learn the latest on COVID-19 contact tracing efforts, the impact of the pandemic on mental health, and how the virus continues to hit marginalized communities the hardest.
This edition of IMPAQ Health News highlights stories on the racial and ethnic disparities of the pandemic, job and health insurance loss, and shifts in hospital operations due to COVID-19.
Read about the latest US response to COVID-19, new research demonstrating how the pandemic is disproportionally affecting communities of color, and an article from IMPAQ experts analyzing past senate responses to public health crises.
Read the latest updates on the US government response to the COVID-19 pandemic, including a $2.2 trillion stimulus package to stabilize the economy, as well as new guidance on social distancing through the end of April.
Learn about the US government response to the COVID-19 pandemic, including several CMS announcements regarding insurance and benefits, as well as a new IMPAQ study on whether coverage limitations on opioid alternatives increase opioid prescription rates.
Read about a Yale study pointing to potential savings under Medicare for All, a Commonwealth Fund report on the impact of the ACA 10 years later, and an update on COVID-19.
Learn about the first maternal mortality report released by NCHS in over 10 years, evidence that pharmaceutical benefit manager (PBM) rebates drive up drug list prices, and IMPAQ's new study on the effectiveness of naloxone access laws in preventing opioid overdose deaths.
In this week's edition, read about CMS' Proposed 2021 Notice of Benefit and Payment Parameter Rule, why chain pharmacies may increase risks to patients, and how new price transparency rules are pushing hospitals and insurers to reveal hidden costs.